ESTRO 2023 - Abstract Book

S709

Monday 15 May 2023

ESTRO 2023

1 The Beatson West of Scotland Cancer Centre, Clinical Oncology, Glasgow, United Kingdom

Abstract Text Re-irradiation is a treatment that is being increasingly offered to patients for several reasons. Outcomes from initial treatment have been improving increasing the chances of developing a second malignancy, surveillance protocols are more commonplace and the radiotherapy technology has developed such that re-irradiation can be offered with significant sparing of normal tissue. There is a growing body of evidence that some patients have durable tumour control after re- irradiation. However, it is a high risk treatment with significant uncertainties. The key concepts of re-irradiation which will be discussed in this talk include radiosensitivity in recurrent disease, uncertainties of dose summation/dose constraints/re-treatment dose, and patients’ attitude to re-irradiation. This talk will review the evidence that informs the current debate about these concepts and discuss future work to further the field.

SP-0843 Brachytherapy for re-irradiation: Concepts and results P. Wojcieszek

Abstract not available

Symposium: The possibility to improve patient care is endless. (Some) initiatives to integrate into radiotherapy departments of the future

SP-0844 Radiobiology is an essential consideration in complete patient care A. Chalmers 1 1 University of Glasgow, School of Cancer Sciences, Glasgow, United Kingdom

Abstract Text Radiation biology has been an essential component in the evolution of modern radiotherapy and continues to play a crucial role in the refinement and improvement of existing treatments and the development and evaluation of new ones. But how many radiotherapy departments employ a dedicated radiobiologist? And how many departments without an ‘in- house’ radiobiologist have access to somebody who might describe themself as such? Having asked that question (and hopefully received some responses from the audience), I will outline some of the ways in which a radiobiologist can enhance the quality of patient care in a radiotherapy department. In preparation for the talk I will contact colleagues in departments across Europe and try to find examples of ‘best practice’ as well as situations where the provision of radiobiology expertise is lacking.

SP-0845 Does a department need to be active in research or trials in order to offer the best patient care? M. Guckenberger Switzerland

Abstract not available

SP-0846 The person in front of us: Complete care for all skin reactions in radiotherapy N. Julka-Anderson 1 1 Imperial College Healthcare NHS Trust, Radiotherapy, London, United Kingdom

Abstract Text There continues to be inequality within radiotherapy skin care assessment. This talk aims to highlight differences in how radiation induced skin reactions present across all skin tones while introducing more inclusive terminology to describe reactions. This terminology will be presented with methods of identifying reactions using touch rather than relying on visualising alone. By using a combination of touch and visuals, patient reported outcomes have the potential to empower patients and healthcare practitioners to work together to identify reactions earlier and provide earlier management. This presentation will introduce anti-racist education to ensure all patients are treated with a person-centred approach to tackle this health inequality.

SP-0847 Living on Fault Lines: Psycho-social issues in cancer survivorship A. Kracen 1 1 National College of Ireland, Psychology, Dublin, Ireland

Abstract Text Psycho-social issues in survivorship are critically important topics for cancer survivors and the professionals who work with them. Enhancing knowledge about patient challenges and opportunities can inform and empower healthcare professionals to feel more competent. Therefore, in this session, I will review facts and myths about survivorship from a psychosocial perspective. Drawing on current research, I will discuss phases of survivorship that people often navigate, while highlighting challenging periods of transition for survivors. Throughout this session, I will discuss strategies for how attendees can support their patients, while also nurturing their own well-being as a healthcare professional.

Joint Symposium: ESTRO-JASTRO: Biology-adjusted radiation therapy

SP-0848 Genomic-adjusted radiation dose J. Scott